Stock GUJTHEM6 GUJARAT THEMIS BIOSYN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Gujarat Themis Biosyn Limited

Equities

GUJTHEM6

INE942C01045

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:49:44 10/05/2024 pm IST 		5-day change 1st Jan Change
398.5 INR +0.61% Intraday chart for Gujarat Themis Biosyn Limited -1.58% +55.33%
10/02 Gujarat Themis Biosyn Limited Approves an Interim Dividend for the Year 2023-24 CI
10/02 Gujarat Themis Biosyn Limited Approves Interim Dividend for the Financial Year 2023-24 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 605.8 571 1,412 2,959 5,920 9,973
Enterprise Value (EV) 1 571.8 615.9 1,476 2,605 5,711 9,888
P/E ratio 15.7 x 8.91 x 5.96 x 9.81 x 13.6 x 17.2 x
Yield - - 1.7% - 1.47% 0.79%
Capitalization / Revenue 1.56 x 1.39 x 1.66 x 3.27 x 5.15 x 6.69 x
EV / Revenue 1.47 x 1.5 x 1.73 x 2.88 x 4.97 x 6.64 x
EV / EBITDA 9.18 x 6.77 x 4.63 x 6.34 x 9.84 x 13.3 x
EV / FCF 9.47 x -7.06 x 63.6 x 9.8 x -103 x 36.4 x
FCF Yield 10.6% -14.2% 1.57% 10.2% -0.97% 2.75%
Price to Book 5 x 3.08 x 3.35 x 4.23 x 5.73 x 6.69 x
Nbr of stocks (in thousands) 72,644 72,644 72,644 72,644 72,644 72,644
Reference price 2 8.340 7.860 19.44 40.73 81.49 137.3
Announcement Date 16/08/18 04/08/19 30/08/20 24/08/21 16/08/22 16/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 388 410.5 851.2 905.6 1,149 1,490
EBITDA 1 62.29 91.03 319 411.1 580.1 743.1
EBIT 1 50.8 78.82 305.4 396.7 565.3 724.9
Operating Margin 13.09% 19.2% 35.88% 43.81% 49.22% 48.66%
Earnings before Tax (EBT) 1 48.38 81.96 312.6 408.8 590.3 774.6
Net income 1 38.67 64.09 236.7 301.8 436.2 579.7
Net margin 9.97% 15.61% 27.81% 33.32% 37.98% 38.91%
EPS 2 0.5320 0.8820 3.259 4.154 6.005 7.980
Free Cash Flow 1 60.37 -87.26 23.19 265.7 -55.56 271.8
FCF margin 15.56% -21.26% 2.72% 29.34% -4.84% 18.24%
FCF Conversion (EBITDA) 96.91% - 7.27% 64.63% - 36.57%
FCF Conversion (Net income) 156.1% - 9.8% 88.03% - 46.88%
Dividend per Share - - 0.3300 - 1.200 1.080
Announcement Date 16/08/18 04/08/19 30/08/20 24/08/21 16/08/22 16/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 44.9 63.8 - - -
Net Cash position 1 34 - - 354 209 84.8
Leverage (Debt/EBITDA) - 0.4933 x 0.2 x - - -
Free Cash Flow 1 60.4 -87.3 23.2 266 -55.6 272
ROE (net income / shareholders' equity) 38.1% 41.8% 78% 53.8% 50.4% 45.9%
ROA (Net income/ Total Assets) 15.1% 18.5% 39.4% 32.6% 33.5% 31.4%
Assets 1 255.3 346.4 600.5 927.1 1,301 1,848
Book Value Per Share 2 1.670 2.550 5.810 9.630 14.20 20.50
Cash Flow per Share 2 0.1200 0.1500 0.1200 0.5500 0.0600 0.8300
Capex 1 10.8 113 32.4 30.6 139 237
Capex / Sales 2.78% 27.64% 3.8% 3.38% 12.1% 15.91%
Announcement Date 16/08/18 04/08/19 30/08/20 24/08/21 16/08/22 16/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
GUJARAT THEMIS BIOSYN LIMITED Stock Gujarat Themis Biosyn Limited
+55.33% 347M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.27B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.52% 22.92B
SANDOZ GROUP AG Stock Sandoz Group AG
+20.29% 15.43B
CIPLA LIMITED Stock Cipla Limited
+7.48% 12.95B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+42.51% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.84% 6.91B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.13% 5.55B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GUJTHEM6 Stock
  4. Financials Gujarat Themis Biosyn Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW